|
|
|
Hookipa Pharma inc (NASDAQ: HOOK) |
|
HOOK's Market share relative to its competitors, as of Q1 2025
As of Q1 2025 (Revenue in Millions of $)
Date modified: 2025-06-23T23:30:16+00:00
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
REVENUES
12 Months Ending
Q1 2025 |
MARKET SHARE
12 Months
Q1 2025 |
MARKET SHARE
MRQ
Q1 2025 |
MARKET SHARE
A Quarter Before
Q4 2024 |
| Hookipa Pharma inc |
9.35 |
0.00% |
0.00 % |
0.00 % |
| Johnson and Johnson |
89,331.00 |
18.80% |
18.73% |
18.46% |
| Merck and Co Inc |
63,922.00 |
13.45% |
13.29% |
12.81% |
| Sanofi |
49,599.72 |
10.44% |
10.44% |
0.00% |
| Eli Lilly And Company |
49,003.20 |
10.31% |
10.89% |
11.09% |
| Bristol myers Squibb Company |
47,636.00 |
10.03% |
9.58% |
10.12% |
| Novartis Ag |
46,660.00 |
9.82% |
9.82% |
0.00% |
| Astrazeneca Plc |
45,811.00 |
9.64% |
9.64% |
0.00% |
| Takeda Pharmaceutical Company Limited |
29,166.69 |
6.14% |
6.14% |
0.00% |
| Gilead Sciences Inc |
28,735.00 |
6.05% |
5.70% |
6.20% |
| Regeneron Pharmaceuticals Inc |
14,085.70 |
2.96% |
2.59% |
3.11% |
| Organon and Co |
6,294.00 |
1.32% |
1.29% |
1.31% |
| Novavax inc |
1,254.96 |
0.26% |
0.57% |
0.07% |
| Emergent Biosolutions Inc |
965.40 |
0.20% |
0.19% |
0.16% |
| Opko Health Inc |
689.41 |
0.15% |
0.13% |
0.15% |
| Hutchmed china Limited |
630.20 |
0.13% |
0.13% |
0.00% |
| Esperion Therapeutics Inc |
259.57 |
0.05% |
0.06% |
0.06% |
| Point Biopharma Global Inc |
243.69 |
0.05% |
0.00% |
0.00% |
| Iovance Biotherapeutics inc |
212.68 |
0.04% |
0.04% |
0.06% |
| Geron Corp |
115.79 |
0.02% |
0.03% |
0.04% |
| Bluebird Bio Inc |
103.95 |
0.02% |
0.03% |
0.03% |
| Journey Medical Corp |
56.24 |
0.01% |
0.01% |
0.01% |
| Merus N v |
54.73 |
0.01% |
0.02% |
0.01% |
| 2seventy Bio Inc |
48.37 |
0.01% |
0.02% |
0.00% |
| Spero Therapeutics Inc |
44.58 |
0.01% |
0.01% |
0.01% |
| Adicet Bio Inc |
38.70 |
0.01% |
0.00% |
0.00% |
| Mirati Therapeutics Inc |
38.19 |
0.01% |
0.01% |
0.01% |
| Sunshine Biopharma Inc |
36.23 |
0.01% |
0.01% |
0.01% |
| Casi Pharmaceuticals inc |
28.54 |
0.01% |
0.01% |
0.00% |
| Iterum Therapeutics Plc |
14.32 |
0.00% |
0.00% |
0.00% |
| Immunome Inc |
12.51 |
0.00% |
0.00% |
0.00% |
| International Stem Cell Corporation |
9.09 |
0.00% |
0.00% |
0.00% |
| Durect Corp |
8.59 |
0.00% |
0.00% |
0.00% |
| Xbiotech Inc |
8.21 |
0.00% |
0.00% |
0.00% |
| Athersys Inc |
5.33 |
0.00% |
0.00% |
0.00% |
| Matinas Biopharma Holdings Inc |
4.28 |
0.00% |
0.00% |
0.00% |
| Prometheus Biosciences Inc |
4.00 |
0.00% |
0.00% |
0.00% |
| Ayala Pharmaceuticals Inc |
3.74 |
0.00% |
0.00% |
0.00% |
| Dmk Pharmaceuticals Corporation |
3.53 |
0.00% |
0.00% |
0.00% |
| Xenetic Biosciences Inc |
2.58 |
0.00% |
0.00% |
0.00% |
| Longeveron Inc |
2.23 |
0.00% |
0.00% |
0.00% |
| Palatin Technologies Inc |
2.18 |
0.00% |
0.00% |
0.00% |
| Humanigen Inc |
1.70 |
0.00% |
0.00% |
0.00% |
| Leap Therapeutics Inc |
1.50 |
0.00% |
0.00% |
0.00% |
| Bellicum Pharmaceuticals Inc |
1.48 |
0.00% |
0.00% |
0.00% |
| Hcw Biologics Inc |
1.45 |
0.00% |
0.00% |
0.00% |
| Tff Pharmaceuticals Inc |
1.28 |
0.00% |
0.00% |
0.00% |
| Actavia Life Sciences Inc |
0.12 |
0.00% |
0.00% |
0.00% |
| Innovation1 Biotech Inc |
0.08 |
0.00% |
0.00% |
0.00% |
| Ampio Pharmaceuticals inc |
0.05 |
0.00% |
0.00% |
0.00% |
| Histogen Inc |
0.02 |
0.00% |
0.00% |
0.00% |
| Sio Gene Therapies Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Hst Global Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Theriva Biologics inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Nkarta Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Genprex Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Immix Biopharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Fibrobiologics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Kezar Life Sciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Alaunos Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Boundless Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| 60 Degrees Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| 180 Life Sciences Corp |
0.00 |
0.00% |
0.00% |
0.00% |
| Tiziana Life Sciences Ltd |
0.00 |
0.00% |
0.00% |
0.00% |
| Viracta Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Forte Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Renovorx Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Indaptus Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Cellectar Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Decibel Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Mineralys Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Third Harmonic Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| Neurogene Inc |
0.00 |
0.00% |
0.00% |
0.00% |
| SUBTOTAL |
475,163.16 |
100% |
116,871.30 |
100% |
HOOK's Market share relative to its competitors, as of Q1 2025 within the Major Pharmaceutical Preparations Industry
As of Q1 2025
HOOK's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
As of Q1 2025
Note: Market share is calculated based on total revenue. To get a more accurate picture of Hookipa Pharma inc's market divisions, geographic dispersion, segments, products, and services, visit Hookipa Pharma inc's Business Segment. The list includes publicly traded companies only. More information about the sources of this report can be found here. |
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
